129
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effectiveness of intermittent preventive treatment with Sulfadoxine-Pyrimethamine in pregnant women in San Pedro, Côte D’Ivoire

, , , , , , , , , & show all

References

  • Chiabi A, Lendem I, Kobela M, et al. Incidence of congenital malaria in two neonatology units in Yaoundé, Cameroon. J pédiatrie puériculture. 2012;25(6):301–308.
  • Abas P. Pathogenesis of gestational malaria. Medicine/science. 2001;17:1017–1026.
  • Brahim BJ, Romagosa F, Abdelgalil C, et al. The sick Placenta – the role of malaria. Placenta. 2004 May;25(5):359–378.
  • Gamain B, Trimnell AR, Scheidig C, et al. Identification of multiple chondroitin sulfate A (CSA)–binding domains in the var2CSA gene transcribed in CSA-binding parasites. J Infect Dis. 2005;191(6):1010–1013.
  • WHO. World malaria report 2017. Geneva: World Health Organization; 2017
  • Botolahy ZA, Randriambelomanana JA, Imbara E, et al. Aspect of Plasmodium falciparum malaria during pregnancy according to observed cases at the teaching hospital of Toamasina Madagascar. Rev Anest Réa Méd Urg. 2011;3(1):23–26.
  • Menendez C. Malaria during pregnancy: a priority area of malaria research and control. Parasitol Today. 1995;11(5):178–183.
  • Toure OA, Penali LK, Coulibaly MA, et al. Comparative efficacy of uncontrolled and controlled intermittent preventive treatment during pregnancy (IPTp) with combined use of LLTNs in high resistance area to sulfadoxine pyrimethamine in Côte d’Ivoire. Infect Drug Resist. 2012;5:53–63.
  • Djaman AJ, Abouanou S, Basco L, et al. Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d’Ivoire): combined in vivo and in vitro studies. Cahier santé. 2004;14(4):205–209.
  • Djaman JA, Kauffy PC, Yavo W, et al. In vivo evaluation of the therapeutic efficacy of sulfadoxine-pyrimethamine combination in uncomplicated malaria in children in Yopougon (Abidjan, Côte d’Ivoire). Bull Soc Pathol Exot. 2004;97(3):180–182.
  • Uneke CJ. Diagnosis of Plasmodium falciparum malaria in pregnancy in sub-Saharan Africa: the challenges and public health implications. Parasitol Res. 2004;102(3):333–342.
  • Mbongo JA, Ekouya BG, Koulimaya GCE, et al. Congenital malaria at the University Hospital Center of Brazzaville: epidemiological study of 90 cases. Health Sci Dis. 2015;16(4). www.hsd-fmsb.org.
  • Yentur DN, Yildiz ZF, Seyrek A. Detection of Plasmodium using filter paper and nested PCR for patients with malaria in Sanliurfa, in Turkey. Malar J. 2016;15(1):299.
  • Paul REL, Hackford I, Brockman A, et al. Transmission intensity and Plasmodium falciparum diversity on the northwestern border of Thailand. AJTMH. 1998;58(2):195–203.
  • Bamba S, Séré A, Nikiéma R, et al. Intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnant women: efficacy and compliance in two urban hospitals in Burkina Faso. Pan Afr Med J. 2013;14:105.
  • Huynh BT, Fievet N, Briand V, et al. Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration. PLoS One. 2012;7(4):e35342.
  • Diouf FN, Faye PM, Ba ID, et al. Prevalence of congenital malaria infestation to Plasmodium falciparum in Ziguinchor hospital regional center/Sénégal. Revue CAMES SANTE. 2015;3(1):67–70.
  • National Malaria Control Program. National Strategic Plan 2016-2020
  • Republic of Côte d’Ivoire - Ministry of Health and AIDS Control, National reproductive health programme. SONU investigation report. 2010.
  • Famanta A, Diakite M, Diawara SI, et al. Prevalence of maternal and placental malaria and of neonatal low birth weight in a semi-urban area of Bamako (Mali). Santé. 2011;21(8):3–7. .
  • Gies S, Coulibaly SO, Ouattara FT, et al. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight. Trop Med Int Health. 2009;14(2):174–182.
  • Diakité OS, Kayentao K, Traoré BT, et al. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in Mali: a randomized controlled trial. Clin Infect Dis. 2011;53(3):215–223. .
  • Tukur IU, Thacher TD, Sagay AS, et al. A comparison of sulfadoxine pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women. Am J Trop Med Hyg. 2007;76(6):1019–1023.
  • Hommerich L, Von-Oertzen C, Bedu-Addo G, et al. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Malar J. 2007;6(1):144. .
  • Sirima SB, Cotte AH, Konaté A, et al. Diarra A, Ouedraogo A. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupéla district, Burkina Faso. Am J Trop Med Hyg. 2006;75(2):205–211.
  • Rogerson SJ, Chaluluka E, Kanjala M, et al. Intermittent sulfadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99. Trans Roy Soc Trop Med Hyg. 2000;94(5):549–553.
  • Mosha D, Chilongola J, Ndeserua R, et al. Effectiveness of intermittent preventive treatment with sulfadoxine–pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania. Trop Med Int Health. 2014;19(9):1048–1056.
  • Casas ES, Menendez C, Doban C, et al. Persistence of Plasmodium falciparum parasites in infected pregnant Mozambican women after delivery. Infect Immun. 2011;79(1):298–304. .
  • Cot M, Deloron P. Paludisme associe à la grossesse: conséquences et perspectives d’intervention. Med Trop. 2003;63:369–380.
  • Ruth EL. Malaria in pregnancy: a literature review. J Midwifery Womens Health. 2008;53(3):24–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.